vs
Side-by-side financial comparison of CuriosityStream Inc. (CURI) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $13.8M, roughly 1.4× FENNEC PHARMACEUTICALS INC.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -34.7%, a 15.0% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 35.8%). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -26.3%).
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
CURI vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $13.8M |
| Net Profit | $-3.8M | $-4.8M |
| Gross Margin | — | — |
| Operating Margin | -17.6% | -18.5% |
| Net Margin | -19.7% | -34.7% |
| Revenue YoY | 35.8% | 73.8% |
| Net Profit YoY | -34.6% | -141.1% |
| EPS (diluted) | $-0.07 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $13.8M | ||
| Q3 25 | $18.4M | $12.5M | ||
| Q2 25 | $19.0M | $9.7M | ||
| Q1 25 | $15.1M | $8.8M | ||
| Q4 24 | $14.1M | $7.9M | ||
| Q3 24 | $12.6M | $7.0M | ||
| Q2 24 | $12.4M | $7.3M | ||
| Q1 24 | $12.0M | $25.4M |
| Q4 25 | $-3.8M | $-4.8M | ||
| Q3 25 | $-3.7M | $-638.0K | ||
| Q2 25 | $784.0K | $-3.2M | ||
| Q1 25 | $319.0K | $-1.2M | ||
| Q4 24 | $-2.8M | $-2.0M | ||
| Q3 24 | $-3.1M | $-5.7M | ||
| Q2 24 | $-2.0M | $-5.6M | ||
| Q1 24 | $-5.0M | $12.8M |
| Q4 25 | -17.6% | -18.5% | ||
| Q3 25 | -24.5% | -1.5% | ||
| Q2 25 | 2.5% | -28.3% | ||
| Q1 25 | 0.5% | -9.2% | ||
| Q4 24 | -27.4% | -11.8% | ||
| Q3 24 | -25.8% | -74.6% | ||
| Q2 24 | -20.6% | -69.4% | ||
| Q1 24 | -30.4% | 54.2% |
| Q4 25 | -19.7% | -34.7% | ||
| Q3 25 | -20.4% | -5.1% | ||
| Q2 25 | 4.1% | -32.7% | ||
| Q1 25 | 2.1% | -13.3% | ||
| Q4 24 | -19.9% | -25.0% | ||
| Q3 24 | -24.3% | -82.2% | ||
| Q2 24 | -16.4% | -76.5% | ||
| Q1 24 | -42.0% | 50.6% |
| Q4 25 | $-0.07 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.02 | ||
| Q2 25 | $0.01 | $-0.11 | ||
| Q1 25 | $0.01 | $-0.04 | ||
| Q4 24 | $-0.05 | $-0.02 | ||
| Q3 24 | $-0.06 | $-0.21 | ||
| Q2 24 | $-0.04 | $-0.20 | ||
| Q1 24 | $-0.09 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.3M | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.5M | $35.5M |
| Total Assets | $75.7M | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | $36.8M | ||
| Q3 25 | $27.8M | $21.9M | ||
| Q2 25 | $28.1M | $18.7M | ||
| Q1 25 | $33.4M | $22.7M | ||
| Q4 24 | $32.1M | $26.6M | ||
| Q3 24 | $33.2M | $40.3M | ||
| Q2 24 | $39.5M | $43.1M | ||
| Q1 24 | $38.8M | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $41.5M | $35.5M | ||
| Q3 25 | $47.2M | $-4.5M | ||
| Q2 25 | $49.8M | $-7.5M | ||
| Q1 25 | $58.1M | $-5.9M | ||
| Q4 24 | $57.8M | $-5.9M | ||
| Q3 24 | $62.2M | $-5.2M | ||
| Q2 24 | $64.8M | $-1.4M | ||
| Q1 24 | $67.0M | $3.0M |
| Q4 25 | $75.7M | $70.6M | ||
| Q3 25 | $74.7M | $49.3M | ||
| Q2 25 | $78.7M | $44.9M | ||
| Q1 25 | $85.3M | $46.4M | ||
| Q4 24 | $86.2M | $44.9M | ||
| Q3 24 | $87.6M | $58.9M | ||
| Q2 24 | $90.9M | $63.2M | ||
| Q1 24 | $94.6M | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-6.0M |
| Free Cash FlowOCF − Capex | $3.9M | — |
| FCF MarginFCF / Revenue | 20.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $-6.0M | ||
| Q3 25 | $4.4M | $1.5M | ||
| Q2 25 | $2.8M | $-3.7M | ||
| Q1 25 | $1.9M | $-4.3M | ||
| Q4 24 | $3.0M | $-1.5M | ||
| Q3 24 | $2.3M | $-2.2M | ||
| Q2 24 | $2.2M | $-8.4M | ||
| Q1 24 | $666.0K | $39.0M |
| Q4 25 | $3.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 20.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
